Avivagen pursuing opportunities for combining OxC-beta with Cannabis products

Avivagen has been analyzing opportunities to combine their propietary product OxC-betaTM with licensed cannabis products and they believe there are various combinations that could result in new products for the company. For the full news release, click here.

“We are enthusiastic about working with leading edge cannabis companies and participating in their development of a line of products which incorporate our unique OxC-beta™ technology,” says Kym Anthony, Chairman and Interim CEO, Avivagen. “We have been vocal advocates for the benefits of new product categories and look forward to collaborating with these large, well-resourced and innovative companies to bring these innovative products to the worldwide market, where appropriate.”

About Avivagen
Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance.  It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com.

Posted in Clients

SomaDetect Chosen for Global Business Accelerator

Emergence client SomaDetect will join other innovators to be part of the 2019 Pearse Lyons Accelerator. In its third year, this Accelerator received 250 applications worldwide and SomaDetect was among only 10 startups chosen. Together they offer a glimpse of what the future of farming will be. See the full list here. These startups will gain access to expertise, funding, networking, presentation and mentorship opportunities that will boost their global success.

This good news adds to their growing list of achievements that include receiving $1M US as the top startup in the Buffalo-based 43North accelerator’s 2017 cohort and, in 2018, investment from the Dairy Farmers of America which represents almost 15,000 farmers. For a full list of achievement, read their news here.

Read more about the Pearse Lyons Accelerator here.

Posted in Clients

We Welcome Active AgriScience

Emergence welcomes its latest client Active AgriScience to Canada’s bioscience incubator program!


Active AgriScience
is an award-winning leading global manufacturer of innovative foliar nutrition products developed to solve grower’s problems and to increase production yields.

Their ground-breaking research conducted by network of laboratories combined with independent third-party verification of efficacy allows growers to improve production, quality, and profits while reducing the impact on the environment.

Headquartered in Abbotsford, BC with manufacturing facilities in Canada and the USA, Active AgriScience exports its products to Asia, Australia, Europe, and across North America. The company’s patented bioactive molecule Intrinsic® offers numerous benefits through each stage of the plant growth cycle. Offering a complete nutritional system for Field Crops, Hydroponic and Organic growers, our key products include Active Prime™, Active Build™, Active Flower™, Active Complete™, Active InFurrow™, and Active Konnect™. More product details here.

Active AgriScience has also developed dual action nitrogen management technology in the form of ARM U™ and ARM U™ ADVANCED. These fertilizer additives when treated to urea drastically enhance plant’s ability to absorb and utilize up to 95% of the available nitrogen, which otherwise, if untreated, volatilizes by as much as 50% through conversion of nitrogen to ammonia gas or leaches into the ground water through nitrification.

Watch their video to learn more:

Meet their team.

Posted in Clients

SomaDetect nominated for 2019 Manning Innovation Awards

Emergence client SomaDetect has been nominated for the 2019 Manning Innovation Awards. The Manning Awards showcases Canada’s leading innovative thinkers and leaders.

SomaDetect is an in-line sensor that measures every critical indicator of dairy quality (fat, protein, somatic cell counts, progesterone, and antibiotics) from every cow at every milking. It uses no consumables (no chemicals, no cartridges, no lost milk), is extremely quick (results in seconds, not minutes), and accurate.

There are four awards from $100,000 to $10,000: Principal Award, Award of Distinction, and two Innovation Awards.

The Manning Awards are named after Earnest C. Manning, former premier of Alberta. He believed in recognizing the intelligence of the common person. The program recognizes Canadians who aspire to “do good for the common good” as this was Manning’s core principle for his own life. Read more here. You can check out former winners here.

We’re behind you and cheering you on!

To learn more about SomaDetect, watch their video:

Posted in Uncategorized

Emergence to participate on Mentorship Matters Panel

Emergence is pleased to be participating on a panel in the upcoming Mentorship Matters event organized by Island Advance on Friday morning, March 8th, 2019, at Rodd Charlottetown Hotel. The theme is how mentorship can help start and grow your business. Rory Francis will present the Emergence/MIT model during the panel focused on “Mentoring to Advance: an overview of mentorship programs available in PEI.” For more details on the event, click here.

Posted in Events, News

Dosecann to add 32 new jobs within next two years

Dosecann CEO Greg Boone (Photo courtesy of CBC)

Emergence client Dosecann, a cannabis oil extraction company in Charlottetown, has plans to add 32 new employees over the next two years which will more than double their team. The PEI Government will offer them labour rebates to support this expansion. CEO Greg Boone says it will allow them to ramp up their team more quickly and be ready with a well-trained team when they enter the production phase.

To read press coverage, please see links below:

Government of PEI news story here:

“It is with great pride that Dosecann calls Charlottetown, PEI, home and the support that we have received from the Province has been instrumental to our success to date. We would like to sincerely thank the Province, Innovation PEI and Skills PEI who have supported our dream of building a world class cannabis company and, on a personal note, for making me feel like an ‘honorary Islander’.”  (CEO Greg Boone)

CBC News story here:

“It probably allows us to bring new people on more quickly,” said Greg Boone, chief executive officer of Dosecann. “And what that does is it really allows us to train them properly, orient them properly and get them up to speed more quickly so that when we go into production, they know exactly what’s happening and what’s going on and where they are supposed to be.”

Dosecann is a Canadian cannabis company dedicated to developing Cannabis Solutions for the global cannabis industry. Proudly located in Charlottetown, PEI, Dosecann has assembled a world-class team housed in a purpose-built, 42,000 sqft GMP compliant facility that will be the hub for cannabis extraction, product innovation and formulation, R&D, quality testing and manufacturing.

Posted in Clients

Emergence client, SomaDetect, secures investment from DFA

Companies around the globe are leveraging innovative technologies and artificial intelligence to make more informed decisions and better run their businesses..

Recently, Dairy Farmers of America (DFA), a national cooperative owned by dairy farm families across the U.S., announced an investment in Emergence client, SomaDetect, a dairy technology startup that will help farmers utilize artificial intelligence to more closely monitor the health of their herd and improve milk quality.

SomaDetect is a dairy technology startup that uses real-time analytics to improve milk quality.

“This is a potentially game-changing technology for our farmers and the industry as it allows dairy farmers to know the health of each cow and quality of milk in real time. With access to better data, our farmers can make more knowledgeable decisions, which is a huge value.”

David Darr, president, farm services at DFA
SomaDetect CEO, Bethany Deshpande, presents at the 2017 Ag Innovation Challenge in Missouri

With SomaDetect’s technology, farmers can easily evaluate components of interest in raw milk, including fat, protein, somatic cells, progesterone and trace antibiotics.

While the technology continues to be refined for commercialization, the platform provides cost-effective, instant analysis, which enables farmers to make rapid and proactive decisions related to the overall health and management of their cows.

SomaDetect recently completed the 2018 Sprint Accelerator program, which is also sponsored by DFA. The Accelerator is a 90-day, immersive program that helps accelerate and grow startup businesses.

SomaDetect CEO, Bethany Deshpande

“DFA and their members have been a great mentor and partner for us, and we’re excited to continue working with them to help bring the SomaDetect platform to dairy farmers across the country.

Dairy farmers have been our greatest teachers and allies throughout the development of our company and technology, and our goal is to show them the same care they show their herd.”

Bethany Deshpande, Founder and CEO at SomaDetect
Posted in Clients

Emergence client, Advanced Extraction Systems, unveils the Largest CO2 Supercritical Fluid Extraction System for the Global Hemp & Cannabis Industries

Emergence client, Charlottetown, PEI-based Advanced Extraction Systems Inc. (AESI), has announced their latest innovation: the highest throughput CO2 extraction system for the global cannabis and hemp markets.  

AESI has designed and engineered a 2X1000L, expandable to 4X1000L, supercritical CO2fluid extraction system capable of processing approximately 4,500kg of dried biomass per day which translates to over 1.6 Million kilograms per annum. Actual yield is based on initial biomass potency. 

“Keeping up with our customers aggressive growth plans has to be at the forefront of our research and development goals. We design our equipment to be modular and expandable to scale up with our customers future capacity requirements.”  

David Campbell, AESI Co-Founder & COO

Nick Desroches, Engineering Manager for AESI told usI, “Coriolis mass-flow meters are standard equipment on every system in our impressive and growing product line.Our newest 2X1000L system demonstrates a ground-breaking 100kg/minute flow-rate which is verified by the Coriolis mass-flow meter.” 

We are very excited to see the Hemp Industry opening up after the passing of the 2019 Farm Bill in the United States.  To date, an industry wide concern for Licensed Producers has been sourcing industrial scale CO2 extraction equipment with the ability to process tons of biomass. Our latest development is the perfect solution with impressive throughput numbers that will help ensure producers can grow their businesses to new heights.”

David Campbell, AESI Co-Founder & COO

In November 2018, AESI won the Emerging Business Award from the Greater Charlottetown Area Chamber of Commerce after demonstrating remarkable growth, innovation, and industry leadership. 

AESI continues to be a pioneer in this emerging industry as their latest development will assist Licensed Producers in meeting demand for oil and CBD related products.

About Advanced Extraction Systems Inc.

AESI designs, engineers and fabricates supercritical fluid CO2 extraction systems with a specific focus in the medical/recreational marijuana and hemp industries. AESI has assembled a skilled management team and a world-class scientific advisory group with over 75 years of experience in supercritical fluid design and processes.  AESI offers the cleanest, most advanced CO2 extraction processes that are leading edge due to the companies ongoing internal focus on research and development. AESI CO2 extraction systems are unique in design, efficiency, and ease of operation. Specifically, AESI systems can be differentiated from the competition in 6 key technical areas; better pump reliability, superior flow rates, superior fractionation, more phase management control, cGMP recipe development, and scalability for future growth.

For further information: David Campbell, Chief Executive Officer, Advanced Extraction Systems Inc., info@advancedextractionsystems.com, 1-877-396-8801, http://www.advancedextractionsystems.com

Posted in Uncategorized

New Licensing Deal for Emergence Client, Simini Technologies

“Pets are part of the family” is a common refrain in the pet and vet industries, but two companies are taking that to heart to help people and their aging pets gain a new lease on life.  

Through connections made at the 2018 Annual Animal Health Homecoming, a new licensing deal was conceived for two young companies aiming to improve both by leveraging the One Health Initiative mindset.  

Motega Health Inc., a biopharmaceutical and food company bringing novel, patented technologies to pharmaceutical and food sciences for human and animal health products, today announced it has executed a licensing agreement with Emergence client, Simini Technologies, Inc., a pharmaceutical company which specializes in licensing veterinary rights to human health drug candidates to develop those products for animal applications.  

 “Motega Health and their world-class team bring a novel approach to active molecules creating diverse products to meet many needs.  Collaborating with Motega has allowed Simini to accelerate a new solution to meet the challenge of muscle loss in aging pets and those with osteoarthritis.” 

Under the terms of the licensing agreement, Motega Health will provide Simini with a North American royalty-bearing license to research, develop, and commercialize a novel therapy for companion animals. Simini will be responsible for all further research and commercial activities under the licensing agreement. Motega Health is eligible for additional undisclosed commercial milestone payments. 

“We are very pleased to be partnering with Simini and their team and are excited by the energy and creative thinking they are bringing to the commercial process in veterinary medicine.”  

Dr. Blake Hawley, CEO of Motega Health

About Simini Technologies, Inc. 

Simini Technologies Inc. is a specialized pharmaceutical company that licenses veterinary rights to human health drug candidates to develop those products for animal applications.   The Company has assembled a robust pipeline of commercialization and development candidates targeting significant animal health conditions including atopic dermatitis, osteoarthritis, aging and infection control.  Learn more about Simini Technologies at http://www.simini.com

About Motega Health Inc.

Motega Health is a biopharmaceutical company dedicated to the discovery, development and licensing of next-generation multifunctional biotherapeutics and commercialization of pharmaceutical, hormone, OTC products, nutraceuticals, foods, and beverages. Motega Health’ suite of complementary therapeutic platforms and its fully-integrated innovation engine provide the flexibility and compatibility to precisely engineer and develop highly-differentiated product candidates. Motega Health is also advancing a deep pipeline of preclinical product candidates and discovery-stage programs in eight therapeutic areas. In addition to Motega Health’s pipeline, it is seeking multiple strategic partnerships with global biopharmaceutical and fast-moving consumer goods companies. http://www.MotegaHealth.com

Posted in Uncategorized

Emergence client, Somru Bioscience, is hiring…

Emergence client, Somru Bioscience Inc. is hiring…

Somru is actively seeking applications from qualified candidates for an R&D Biosimilar Manufacturing Manager.

Somru is an emerging biotechnology company dedicated to developing breakthrough antibody technology for research, diagnostic and therapeutic applications.

The company utilizes a unique and proprietary Somru™ technology which produces antibodies with superior binding affinity and bioactivity in a wide variety of biological assays in a short period of time.

They also offer a wide range of quality reagents for research and diagnostics applications as well as for biosimilar research and development.

Posted in Clients